Search Results 471-480 of 16820 for GLP-1 agonists
The purpose of this study is to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants with Glanzmann ...
What Is the Role of Glucagon-Like Peptide 1 Signaling in the Nervous System and Its Potential Neuroprotective Effects? Neurology. 2024 Aug 27; 103 (4): ...
Patients on gonadotropin-releasing hormone (GnRH) agonists (e.g., for prostate cancer) are not excluded. Patients receiving bisphosphonates or denosumab are ...
For treatment of HIV infection: Adults and children weighing 35 kilograms (kg) or more—1 tablet once a day with food. Each tablet contains 200 milligrams (mg) ...
The primary purpose of this study is to evaluate the impact of dapagliflozin, as compared with placebo, on heart failure, disease specific biomarkers, symptoms, ...
September 1, 2025. Mayo Clinic research set to launch aboard NASA mission to International Space Station to explore new. Research. Mayo Clinic research set to ...
JACKSONVILLE, Fla. — A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking ...
But if it does control one of those areas, we have other options now available that a lot of other centers don't have — electrical stimulation options and ...
2021 Dec 1; 33 (1S Suppl 1):e1039-e1041. View PubMed; Hughes DC, Baehr LM, Driscoll JR, Lynch SA, Waddell DS, Bodine SC. Identification and characterization ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!